4//SEC Filing
Grunberg Gregory 4
Accession 0001415889-21-003120
CIK 0001479419other
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 5:30 PM ET
Size
8.6 KB
Accession
0001415889-21-003120
Insider Transaction Report
Form 4
Grunberg Gregory
Director10% Owner
Transactions
- Award
Common Stock
2021-06-17+20,000→ 40,000 total
Holdings
- 2,877,006(indirect: By Longitude Venture Partners II, L.P.)
Common Stock
- 2,534,854(indirect: By Longitude Venture Partners IV, L.P.)
Common Stock
Footnotes (4)
- [F1]Grant of restricted stock units ("RSUs") under the Issuer's 2017 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the reporting person's continued service with the Issuer, the RSUs will vest as to 100% of the shares underlying the RSUs on the earlier of (i) June 17, 2022 or (ii) the date of the first annual meeting following June 17, 2021.
- [F2]Includes 20,000 unvested RSUs.
- [F3]Longitude Capital Partners IV, LLC ("LCP IV") is the general partner of Longitude Venture Partners IV, L.P. ("LVP IV") and may be deemed to have voting and investment power with respect to such securities. Patrick G. Enright and Juliet Tammenoms Bakker are the managing members of LCP IV and may be deemed to share voting and investment power over the securities held by LVP IV. The Reporting Person is a member of LCP IV and may be deemed to share voting and investment power over the securities of the issuer held by LVP IV. Mr. Enright, Ms. Tammenoms Bakker and the Reporting Person (a member of the Issuer's board of directors) disclaim beneficial ownership over such securities except to the extent of their respective pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose.
- [F4]Longitude Capital Partners II, LLC ("LCP II") is the general partner of Longitude Venture Partners II, L.P. ("LVP II") and may be deemed to have voting and investment power with respect to such securities. Patrick G. Enright and Juliet Tammenoms Bakker are the managing members of LCP II and may be deemed to share voting and investment power over the securities held by LVP II. The Reporting Person is a member of LCP II and may be deemed to share voting and investment power over the securities of the issuer held by LVP II. Mr. Enright, Ms. Tammenoms Bakker and the Reporting Person (a member of the Issuer's board of directors) disclaim beneficial ownership over such securities except to the extent of their respective pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose.
Documents
Issuer
Kala Pharmaceuticals, Inc.
CIK 0001479419
Entity typeother
Related Parties
1- filerCIK 0001711080
Filing Metadata
- Form type
- 4
- Filed
- Jun 20, 8:00 PM ET
- Accepted
- Jun 21, 5:30 PM ET
- Size
- 8.6 KB